Tumor-doubling time and onset of pulmonary metastasis from adenoid cystic carcinoma of the salivary gland.
Adenoid cystic carcinoma (ACC), an uncommon malignancy in the head and neck region, invades diffusely and often metastasizes to the lung, although the growth rate is very slow. A retrospective study was conducted in 30 patients with ACC to ascertain the frequency of pulmonary metastasis, the doubling time of metastatic tumor deposits, and the time of onset for pulmonary metastasis. The following results were obtained: (1) Of 30 patients with ACC, 21 had pulmonary metastases (4 initially and 17 during observation), 7 were free of metastases but have not been observed for 5 years, and 2 were free of metastases for more than 5 years but less than 10 years after the initial treatment. The cumulative metastasis rate at 5 and 10 years for this group of patients was 70% and 100%, respectively. (2) Patients with T1 or T2 tumors that have a tubular or cribriform histopathologic pattern showed pulmonary metastases about 20 months later than those with T3 or T4 tumors and a solid pattern. However, the final metastasis rate did not differ between the 2 groups after a long period. (3) The tumor doubling time of the metastatic deposits of ACC was 86 to 1064 days with an average of 393 days, which was much longer than that of most other malignant neoplasms reported previously. (4) The time of onset of pulmonary metastasis was calculated to be much earlier (average of 227 months) before the first visit. These findings suggest that the treatment method for ACC should be chosen with the consideration that many of the patients may have occult pulmonary metastases at the time of their initial evaluation.
Umeda
M
M
Kobe University School of Medicine, Department of Oral and Maxillofacial Surgery, Japan.
Nishimatsu
N
N
Masago
H
H
Ishida
Y
Y
Yokoo
S
S
Fujioka
M
M
Shibuya
Y
Y
Komori
T
T
D003528:Carcinoma, Adenoid Cystic / Q000000981:diagnostic imaging / Q000401:mortality / Q000473:pathology*; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000556:secondary*; D009367:Neoplasm Staging; D011379:Prognosis; D013902:Radiography, Thoracic; D012468:Salivary Gland Neoplasms / Q000000981:diagnostic imaging / Q000401:mortality / Q000473:pathology*; D013997:Time Factors